Malaria News and Research

Latest Malaria News and Research

Chemotherapy drugs also kill malaria parasite

A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.

9 Mar 2011

New insight into malaria

A group of researchers from EPFL's Global Health Institute and Inserm has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.

8 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.

7 Mar 2011

Recent releases in Global Health

The Importance Of Investing In Adolescent Girls: A Lancet editorial examines the challenges adolescent girls living in developing countries face and the work of the U.N. Adolescent Girls Task Force to help young women overcome these barriers.

5 Mar 2011

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.

5 Mar 2011

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today.

4 Mar 2011

Protesters call on Indian government to reject free trade agreement with EU

Thousands of HIV-positive people from India and across Asia marched in New Delhi on Wednesday to protest the proposed free trade agreement between the European Union and India, "which has provisions that would restrict access to affordable medicines," the Times of India reports.

4 Mar 2011

Clinton defends State Department budget requests before House panel

In her testimony before the House Foreign Affairs Committee on Tuesday about President Barack Obama's FY12 budget request, Secretary of State Hillary Rodham Clinton also defended the State Department's FY11 budget request, Bloomberg reports. Clinton said the proposed budget cuts for FY11 would be "devastating" to U.S. national security, and U.S. programs in Afghanistan, Pakistan and Iraq would see "sharp reductions" if the proposed cuts are passed.

3 Mar 2011

Britain to cut foreign aid for 16 countries, focus more on family planning, safe water, maternal mortality

British Secretary of State for International Development Andrew Mitchell on Tuesday announced major changes to the nation's international aid program based on a nine-month review of the agency's policies, Reuters reports.

3 Mar 2011

Inter Press Service explores how Kenya's Anti-Counterfeit Act, possible EU-India free trade agreement could scale back access to affordable medications

Inter Press Service examines how legislation in Kenya targeting counterfeit medications and a possible EU-India Free Trade Agreement could scale back access to affordable and safe generic medications widely used in developing countries.

2 Mar 2011

New insight into HIV/AIDS

A paper published in the March 2011 print edition of the Journal of Clinical Investigation offers new insight into what prompts immunity to AIDS in sooty mangabeys, a natural host African monkey species.

2 Mar 2011

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.

2 Mar 2011

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

VaxInnate Corporation today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, worth up to $196 million to fund the development of recombinant seasonal and pandemic flu vaccines.

1 Mar 2011

U.K.'s DFID might reduce funding for FAO in light of 'patchy' performance

The U.K.'s Department for International Development on Saturday said it might reduce its contribution to the U.N. Food and Agriculture Organization if the agency does not improve its performance, Reuters reports.

1 Mar 2011

NIH-funded study finds way to reduce transmission of malaria to humans

Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.

25 Feb 2011

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of the first reported case in which adenovirus infection was successfully eradicated following treatment with its broad-spectrum antiviral drug, CMX001.

25 Feb 2011

Transgenic fungal approach can fight against malaria and bug-borne diseases

New findings by a University of Maryland-led team of scientists indicate that a genetically engineered fungus carrying genes for a human anti-malarial antibody or a scorpion anti-malarial toxin could be a highly effective, specific and environmentally friendly tool for combating malaria, at a time when the effectiveness of current pesticides against malaria mosquitoes is declining.

24 Feb 2011

Opinions: Foreign aid lessons from Britain; food security; Global Fund investigation; U.S. food aid cuts; Africa needs trade

"Before Republican budget hawks wield their knife, ... they should take a lesson from their conservative cousins in the United Kingdom: When belt-tightening gets serious, foreign aid should be improved, not gutted," according to an opinion piece in the New Republic written by Thomas Carothers, vice president for studies at the Carnegie Endowment for International Peace.

24 Feb 2011

Daily report global health conversations: Health sector corruption

Recent media reports have drawn attention to an internal audit that revealed several countries' misuse of Global Fund to Fight AIDS, Tuberculosis and Malaria grant money, totaling $34 million.

24 Feb 2011

Malaria News and Research

Latest Malaria News and Research

Chemotherapy drugs also kill malaria parasite

New insight into malaria

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Recent releases in Global Health

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

Protesters call on Indian government to reject free trade agreement with EU

Clinton defends State Department budget requests before House panel

Britain to cut foreign aid for 16 countries, focus more on family planning, safe water, maternal mortality

Inter Press Service explores how Kenya's Anti-Counterfeit Act, possible EU-India free trade agreement could scale back access to affordable medications

New insight into HIV/AIDS

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

U.K.'s DFID might reduce funding for FAO in light of 'patchy' performance

NIH-funded study finds way to reduce transmission of malaria to humans

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Transgenic fungal approach can fight against malaria and bug-borne diseases

Opinions: Foreign aid lessons from Britain; food security; Global Fund investigation; U.S. food aid cuts; Africa needs trade

Daily report global health conversations: Health sector corruption

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in